Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab. (Q34627103)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

based on heuristic

inferred from title

thromboembolism

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

Ângela M. Carneiro

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

Manuel S. Falcão

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

Fernando Faria-Correia

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

Fernando Falcao-Reis

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Daniel Barthelmes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

Luis S Mendonça

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

Rita M Gonçalves

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

publication date

18 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

Ophthalmologica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

225

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

211-221

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

The epidemiology of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Angiogenesis as a therapeutic target

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Retinal angiogenesis in development and disease

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Targeting VEGF-A to treat cancer and age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Pegaptanib for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Vascular events in patients with age-related macular degeneration treated with intraocular bevacizumab

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Intravitreal bevacizumab for neovascular age-related macular degeneration with or without prior treatment with photodynamic therapy: one-year results

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Age-related macular degeneration and risk for stroke

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Age-related macular degeneration and mortality from cardiovascular disease or stroke

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Is age-related macular degeneration associated with stroke among elderly americans?

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: the second year of a prospective study.

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

A prospective study of blood pressure and intraocular pressure changes in hypertensive and nonhypertensive patients after intravitreal bevacizumab injection.

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies.

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

First diabetes prevalence study in Portugal: PREVADIAB study

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Prospective community-based study of stroke in Northern Portugal: incidence and case fatality in rural and urban populations

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Adherence to the Southern European Atlantic Diet and occurrence of nonfatal acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Increasing trends of acute myocardial infarction in Spain: the MONICA-Catalonia Study

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Ten-year fatal and non-fatal myocardial infarction incidence in elderly populations in Spain: the EPICARDIAN cohort study

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Body mass index and the incidence of visually significant age-related maculopathy in men

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Comparative effects of bevacizumab, ranibizumab and pegaptanib at intravitreal dose range on endothelial cells.

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Bevacizumab treatment for cancer patients with cardiovascular disease: a double edged sword?

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Pharmacokinetics of intravitreal ranibizumab (Lucentis).

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

1 reference

https://api.crossref.org/works/10.1159/000323943

21 January 2018

Identifiers

10.1159/000323943

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21336001 AND SRC:MED&resulttype=core&format=json

23 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34627103&oldid=2043615918"